James P. Quinlan - 13 Aug 2025 Form 4 Insider Report for Medicus Pharma Ltd. (MDCX)

Reporting relationship: Chief Financial Officer
Issuer ticker: MDCX
Reported as of: 13 Aug 2025
Net transaction value: +$156,250
SEC form: 4
Accepted by SEC: 14 Aug 2025, 16:01:38 UTC
Prior SEC filing: 24 Jul 2025
Source filing: View source filing
Reporting owner signature: /s/ James P. Quinlan

Key filing fact

James P. Quinlan filed Form 4 for Medicus Pharma Ltd. (MDCX) on 14 Aug 2025.

Key facts

This page summarizes James P. Quinlan's Form 4 filing for Medicus Pharma Ltd. (MDCX).
4 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 14 Aug 2025, 16:01.

Change

Previous filing in this sequence was filed on 24 Jul 2025.
Current net transaction value: +$156,250.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002047493 Primary reporting owner

Quinlan James P.

Relationship: Chief Financial Officer
Address: 300 CONSHOHOCKEN STATE ROAD, SUITE 200, W.CONSHOHOCKEN
Signature: /s/ James P. Quinlan
Signature date: 14 Aug 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MDCX transaction

Common Shares, no par value ("Common Shares")

Options Exercise

Transaction value: $101,250
Shares: +125,000
Change %: +97%
Price: $0.8100
Shares after: 254,147
Date: 13 Aug 2025
Ownership: Direct
Footnotes: F1

MDCX transaction

Common Shares

Options Exercise

Transaction value: $55,000
Shares: +20,000
Change %: +7.9%
Price: $2.75
Shares after: 274,147
Date: 13 Aug 2025
Ownership: Direct
Footnotes: F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MDCX transaction Derivative

Stock Option (right to buy)

Options Exercise

Transaction value: $0
Shares: -125,000
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 13 Aug 2025
Ownership: Direct
Underlying class: Common Shares
Underlying amount: 125,000
Exercise price: $0.8100
Footnotes: F1, F3

MDCX transaction Derivative

Stock Option (right to buy)

Options Exercise

Transaction value: $0
Shares: -20,000
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 13 Aug 2025
Ownership: Direct
Underlying class: Common Shares
Underlying amount: 20,000
Exercise price: $2.75
Footnotes: F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Represents an exercise price of $1.16 Canadian dollars, converted to U.S. dollars at the daily average exchange rate of $1.00 to CAD$1.4379 reported by the Bank of Canada on December 30, 2024.

Footnote F2

Represents an exercise price of $3.95 Canadian dollars, converted to U.S. dollars at the daily average exchange rate of $1.00 to CAD$1.4379 reported by the Bank of Canada on December 30, 2024.

Footnote F3

The option was vested and was exercisable as of the Transaction Date.